Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 100 shares, a decrease of 88.9% from the February 28th total of 900 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 5,700 shares, the short-interest ratio is presently 0.0 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC increased its holdings in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 8.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 583,615 shares of the company’s stock after acquiring an additional 43,788 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 27.79% of Fidelity Disruptive Medicine ETF worth $14,392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Fidelity Disruptive Medicine ETF Stock Performance

Shares of NASDAQ FMED traded down $0.49 during mid-day trading on Wednesday, hitting $24.17. 2,260 shares of the stock traded hands, compared to its average volume of 5,443. The company has a market cap of $50.77 million, a price-to-earnings ratio of 42.35 and a beta of 0.94. The stock has a fifty day moving average price of $25.37 and a 200-day moving average price of $25.62. Fidelity Disruptive Medicine ETF has a 52 week low of $23.32 and a 52 week high of $26.79.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.